
companies
Eli Lilly sees surging sales in contrast to obesity rival Novo
Drugmaker projected robust sales, solidifying its dominance in the weight-loss drug sector as demand soars and rival Novo Nordisk faces headwinds
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC